A U.S. Court of Appeals has affirmed a preliminary injunction against several alternative funding programs (AFPs) and associated businesses, a decision that could significantly reshape the landscape for these health initiatives. The ruling, which favors pharmaceutical giant Gilead Sciences, addresses the controversial practice of importing medications from overseas, a method federal authorities have consistently deemed […]